Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AstraZeneca forges licensing agreement with Redx Pharma

The Pharma Data

AstraZeneca has signed a licensing deal with UK-based biotech company Redx Pharma for its fibrotic disease candidate RXC006. AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset.

Cytiva licenses Allen Institute’s advanced machine learning technology

Scienmag

Strategic license to advance the field of 3D and live cell imaging Credit: Allen Institute Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute’s machine learning technology with Cytiva’s microscopy and image analysis systems to advance the development of cell imaging innovations.

Gilead licenses Jounce immunotherapy for $800m

Pharma Phorum

billion collaboration deal with Jounce, under which both companies would develop multiple cancer immunotherapies, but in the wake of Celgene’s acquisition by BMS the company restructured the deal to instead commit up to $530 million for global licensing rights to another Jounce drug, JTX-8064.

Columbia Care Awarded Cultivation License by West Virginia Office of Medical Cannabis

BioTech 365

NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announced today the Company has received a medical cultivation license from the West Virginia Office of Medical Cannabis. NEW YORK–(BUSINESS WIRE)–Columbia Care Inc.

Calviri, Inc. Receives Exclusive Patent License to Immunosignature Technology, Strengthening Its Disease Diagnostic Capabilities

BioTech 365

a biotech startup focused on ending deaths from cancer, announces that Skysong Innovations, the intellectual property management company for Arizona State University (“ASU”), granted Calviri an exclusive license to ASU’s Immunosignature patent portfolio. TEMPE, Ariz.–(BUSINESS

AstraZeneca forges licensing agreement with Redx Pharma

Pharma Times

AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset

IONTAS Announces Mammalian Display Licensing Agreement With Bristol Myers Squibb

BioTech 365

Juvenescence Announces Licensing Agreement with Evgen Pharma plc

BioTech 365

DOUGLAS, Isle of Man–(BUSINESS WIRE)–Juvenescence Limited (“Juvenescence”), a life sciences company focused on modifying aging and increasing human healthspan, announced today a partnership with Evgen Pharma plc to license its sulforaphane stabilization technology for use in several non-pharmaceutical applications led … Continue reading → Business Wire

Rentschler Biopharma and ATUM Announce Leap-In Transposase® Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins

BioTech 365

Prometheus Fuels licenses energy-saving ORNL ethanol-to-jet-fuel process

Scienmag

of Energy Prometheus Fuels has licensed an ethanol-to-jet-fuel conversion process developed by researchers at the Department of Energy’s Oak Ridge National Laboratory. Credit: Carlos Jones/ORNL, U.S.

Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen

BioTech 365

Company Announcement Copenhagen, Denmark; September 22, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that it has commenced binding arbitration of two matters arising under its license agreement with Janssen Biotech, Inc. Under the license agreement, … Continue reading → GlobeNewswire

Merck KGaA out-licenses osteoarthritis programme to Novartis

Pharma Times

Potential disease modifying osteoarthritis candidate is phase II ready

Final two journals in the 2020 pilot program use Subscribe to Open to publish volumes OA

Scienmag

Atmospheric Science Chemistry/Physics/Materials Sciences Earth Science Licenses/Patents

Terrace Global Announces Receipt of Pre-License for Outdoor Medical Cannabis Cultivation in Portugal

BioTech 365

TORONTO–(BUSINESS WIRE)–Terrace Global Inc. (“Terrace Global” or the “Corporation”) (TSXV: TRCE) is pleased to announce it has been granted a provisional license (the “Pre-License”) from INFARMED, I.P.,

Brink Biologics Announces License Agreement with Global Healthcare Company Fresenius Kabi SwissBioSim GmbH

BioTech 365

NASDAQ: NK) affiliate and exclusively-licensed distributor of NantKwest’s proprietary off-the-shelf NK-92® natural killer cells in certain fields, announces the licensing of its next-generation natural killer-based bioanalytical testing solution to Fresenius Kabi … Continue reading → Business WireSAN DIEGO–(BUSINESS WIRE)–Brink Biologics, Inc. (“Brink”), a NantKwest, Inc.

Virtual driving assessment shows feasibility, validity, efficiency as part of licensing

Scienmag

2020 pandemic and subsequent revisions to state licensing procedures underscore how widespread adoption could keep drivers safe in challenging times while also improving evaluation Philadelphia, October 5, 2020 -Researchers from Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania’s Annenberg Public Policy Center have demonstrated the feasibility of incorporating a virtual driving assessment system […].

Blackrock Microsystems Licenses Wyss Center’s Real-time Neural Signal Processing Platform

BioTech 365

Iksuda Therapeutics exercises licensing rights from University of Goettingen

Pharma Times

Agreement covers protein-alkylating, tumour-activated pro-drug payload series for ADC development

Vifor Pharma and Cara Expand Licensing Deal for Late-Stage Kidney Disease Drug

BioSpace

Under terms of the deal, Connecticut-based Cara Therapeutics will receive $100 million in an upfront payment, as well as an equity investment of $50 million. Additional milestone payments could bring the total of the deal to about $290 million

More than 90% of driver’s license suspensions are not related to traffic safety

Scienmag

Suspensions disproportionately affect low income, Black and Hispanic families and may severely limit access to employment and healthcare Philadelphia, September 29, 2020 – A study conducted by researchers at Children’s Hospital of Philadelphia (CHOP) and Brown University found that the vast majority of license suspensions are for non-driving-related events, such as failure to pay a […].

IBRI Licenses Rapid-Testing Technology for Infectious Diseases

BioSpace

Point-of-care testing is a critical tool in the battle against COVID-19, and researchers in Indiana are working around the clock to deliver rapid tests with high specificity

DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms 

BioTech 365

DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms Leiden, The Netherlands, and Berlin, Germany, September 21, 2020 – DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage … Continue reading → GlobeNewswire

Seneca Therapeutics, Inc. Licenses Tumor Endothelial Marker 8 (TEM8) to Enable Better Patient Selection for SVV-001 Therapy

BioTech 365

a clinical-stage biopharmaceutical company dedicated to the development of oncolytic immune-therapeutics based on Seneca Valley Virus (SVV-001), announced today the company has licensed TEM 8 intellectual property from Memorial Sloan Kettering Cancer Center (MSK).

Sanofi acquires Principia; FDA’s Nod to Roche’s Enspryng; BMS, Dragonfly’s Licensing Deal

Delveinsight

Sanofi had earlier licensed-in Principia’s experimental multiple sclerosis treatment ‘168; the late-stage pemphigus treatment Rilzabrutinib; and PRN473, a topical BTK inhibitor. USD 475 Million Deal: BMS Inks An A Global License Deal With Dragonfly For Immunotherapy Program .

Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics

BioTech 365

BILLERICA, Mass.–(BUSINESS

2020 Zika Virus Market Spotlight: Key Pipeline Therapies, Clinical Trials, Probability of Success, Epidemiology, and Licensing and Acquisition Deals – ResearchAndMarkets.com

BioTech 365

This Market Spotlight report covers the Zika virus market, comprising key pipeline therapies, clinical trials, probability of success, epidemiology, and licensing and acquisition deals. DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Zika Virus” report has been added to ResearchAndMarkets.com’s offering.

AnHeart Licenses Two Clinical Stage Oncology Candidates from Daiichi Sankyo

BioTech 365

Expanding Oncology Pipeline to Three Novel Molecules Following its Series A+ Financing Round HANGZHOU, China and NEW YORK, Sept. 07, 2020 (GLOBE NEWSWIRE) — AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global … Continue reading → GlobeNewswire

Polyphor Announces Closing of Fosun Pharma Licensing Agreement for balixafortide in China and Receipt of $15 Million Upfront Payment

BioTech 365

29, 2020 (GLOBE NEWSWIRE) — Polyphor AG (SIX: POLN) today announced the closing of the previously announced exclusive licensing agreement with Fosun Pharma for balixafortide in China. ALLSCHWIL, Switzerland, Sept. As a result of closing the transaction, Polyphor received the … Continue reading → GlobeNewswire

Finding hidden treasures in old drugs: the challenges and importance of licensing generics

Drug Patent Watch

The post Finding hidden treasures in old drugs: the challenges and importance of licensing generics appeared first on DrugPatentWatch - Make Better Decisions. This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, and Chris J.J.

FDA approves the guardian needle, a solution for reducing accidental needle sticks

Scienmag

Medicine & Health Biomedical/Environmental/Chemical Engineering Biotechnology Health Professionals Licenses/Patents Medicine/Health Neurobiology Surgery Technology Transfer

Busy Rain Therapeutics Licenses 2 Oncology Assets, Closes $63 Million Series B

BioSpace

Privately-held Rain Therapeutics closed a $63 million Series B financing round that will be used to advance the company’s pipeline of targeted cancer therapies, including RAIN-32, its recently acquired asset from Daiichi Sankyo

Generex Signs Binding Licensing & Research Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Malaysia

BioTech 365

Bintai Kinden Corporation Berhad (www.bintai.com.my) is an investment holding company headquartered in Malaysia with operations throughout South-East Asia, China, and the Arabian Gulf Region Upfront licensing fee of $2.5 million 100% funding for development, manufacturing and commercial registration of Ii-Key- … Continue reading → GlobeNewswire

UK biotech in licensing deal with BMS on antibodies screening tool

BioPharma Reporter

IONTAS has announced a deal with Bristol Myers Squibb (BMS) in relation to its platform for antibody identification. Bio Developments

Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery

BioTech 365

Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that its licensing … Continue reading → GlobeNewswireALPHARETTA, Ga., 11, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc.

Dragonfly Therapeutics and Bristol Myers Squibb Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program

The Pharma Data

NEW YORK & WALTHAM, Mass.–(

First payment of EUR 20 million received for strategic licensing deal in China

BioTech 365

Collaboration with CGN Nuclear Technology Development Co., Ltd worth a minimum of EUR 100 million Louvain-La-Neuve, Belgium, 24 September 2020 – IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, … Continue reading → GlobeNewswire

City of Hope Enters Licensing Agreement With Chimeric to Develop Its Pioneering Chlorotoxin CAR T Cell Therapy

BioTech 365

The comprehensive cancer center has also dosed its first patient in chlorotoxin CAR T cell therapy trial DUARTE, Calif.–(BUSINESS

Springer Nature extends digital flexibility in its new eBook offers

Scienmag

Social & Behavioral Science Business/Economics Education Learning/Literacy/Reading Licenses/PatentsLibraries and research institutions to have more choice and greater flexibility in order to access digital book content in ways that work for them. Springer Nature is providing libraries and research institutions with a broader range of choice in how they purchase and access digital book content. Its new eBook solutions will provide librarians in […].